Skip to main content

Table 3 Univariate analysis for prognostic factors

From: Impact of superselective intra-arterial and systemic chemoradiotherapy for gingival carcinoma; analysis of treatment outcomes and prognostic factors

Variables

OS

PFS

LC

HR

95% CI

P value

HR

95% CI

P value

HR

95% CI

P value

Age, years

<  65

1/reference

  

1

  

1

  

≥ 65

4.655

1.389–15.59

0.003

2.618

0.992–6.906

0.033

3.1035

1.067–9.028

0.019

Gender

Female

1

  

1

  

1

  

Male

2.021

0.906–4.505

0.076

1.312

0.630–2.733

0.466

1.324

0.618–2.833

0.468

ECOG PS

0

1

  

1

  

1

  

>  1

2.555

1.168–5.589

0.024

2.013

0.925–4.382

0.091

1.893

0.8399–4.265

0.139

Clinical stage

≤ stage 3

1

  

1

  

1

  

> stage 4

2.583

0.874–7.632

0.058

2.905

0.994–8.490

0.029

3.715

1.099–12.56

0.014

T category

≤ T3

1

  

1

  

1

  

> T3

1.204

0.548–2.649

0.642

2.316

0.984–5.453

0.041

2.567

1.0298–6.399

0.029

N category

≤ N2b

1

  

1

  

1

  

> N2b

2.794

1.077–7.252

0.052

4.117

1.722–9.845

0.004

4.430

1.831–10.72

0.003

Location

Lower

1

  

1

  

1

  

Upper

0.909

0.423–1.950

0.806

0.796

0.382–1.658

0.542

0.7923

0.370–1.695

0.548

Chemotherapy

IACRT

1

  

1

  

1

  

SCRT

2.34

1.012–5.41

0.047

2.334

1.058–5.149

0.048

2.586

1.156–5.786

0.030

RT field

primary tumor

1

  

1

  

1

  

cervical LN area

0.727

0.171–3.098

0.680

1.492

0.348–6.390

0.6099

1.591

0.369–6.858

0.558

Prescribed total dose

≤60 Gy

1

  

1

  

1

  

> 60 Gy

1.003

0.438–2.299

0.993

2.225

1.066–4.65

0.0378

2.177

1.015–4.672

0.0515